BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32165297)

  • 1. Hypoxia-induced elevated NDRG1 mediates apoptosis through reprograming mitochondrial fission in HCC.
    Guo DD; Xie KF; Luo XJ
    Gene; 2020 May; 741():144552. PubMed ID: 32165297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia and retinoic acid-inducible NDRG1 expression is responsible for doxorubicin and retinoic acid resistance in hepatocellular carcinoma cells.
    Jung EU; Yoon JH; Lee YJ; Lee JH; Kim BH; Yu SJ; Myung SJ; Kim YJ; Lee HS
    Cancer Lett; 2010 Dec; 298(1):9-15. PubMed ID: 20573444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NDRG1 regulates osteosarcoma cells via mediating the mitochondrial function and CSCs differentiation.
    Zhao T; Meng Y; Wang Y; Wang W
    J Orthop Surg Res; 2021 Jun; 16(1):364. PubMed ID: 34099022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FOXQ1/NDRG1 axis exacerbates hepatocellular carcinoma initiation via enhancing crosstalk between fibroblasts and tumor cells.
    Luo Q; Wang CQ; Yang LY; Gao XM; Sun HT; Zhang Y; Zhang KL; Zhu Y; Zheng Y; Sheng YY; Lu L; Jia HL; Yu WQ; Liu J; Dong QZ; Qin LX
    Cancer Lett; 2018 Mar; 417():21-34. PubMed ID: 29248714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NDRG1 as a biomarker for metastasis, recurrence and of poor prognosis in hepatocellular carcinoma.
    Cheng J; Xie HY; Xu X; Wu J; Wei X; Su R; Zhang W; Lv Z; Zheng S; Zhou L
    Cancer Lett; 2011 Nov; 310(1):35-45. PubMed ID: 21763068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia increases cytoplasmic expression of NDRG1, but is insufficient for its membrane localization in human hepatocellular carcinoma.
    Sibold S; Roh V; Keogh A; Studer P; Tiffon C; Angst E; Vorburger SA; Weimann R; Candinas D; Stroka D
    FEBS Lett; 2007 Mar; 581(5):989-94. PubMed ID: 17316623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TPX2 silencing exerts anti‑tumor effects on hepatocellular carcinoma by regulating the PI3K/AKT signaling pathway.
    Huang DH; Jian J; Li S; Zhang Y; Liu LZ
    Int J Mol Med; 2019 Dec; 44(6):2113-2122. PubMed ID: 31638175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased mitochondrial fission promotes autophagy and hepatocellular carcinoma cell survival through the ROS-modulated coordinated regulation of the NFKB and TP53 pathways.
    Huang Q; Zhan L; Cao H; Li J; Lyu Y; Guo X; Zhang J; Ji L; Ren T; An J; Liu B; Nie Y; Xing J
    Autophagy; 2016 Jun; 12(6):999-1014. PubMed ID: 27124102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of FRAT1 inhibits hypoxia-induced epithelial-to-mesenchymal transition via suppression of the Wnt/β-catenin pathway in hepatocellular carcinoma cells.
    Fan WH; Du FJ; Liu XJ; Chen N
    Oncol Rep; 2016 Nov; 36(5):2999-3004. PubMed ID: 27666874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial UQCC3 Modulates Hypoxia Adaptation by Orchestrating OXPHOS and Glycolysis in Hepatocellular Carcinoma.
    Yang Y; Zhang G; Guo F; Li Q; Luo H; Shu Y; Shen Y; Gan J; Xu L; Yang H
    Cell Rep; 2020 Nov; 33(5):108340. PubMed ID: 33147459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic anti-tumor efficacy of doxorubicin and flavopiridol in an in vivo hepatocellular carcinoma model.
    Kwak MS; Yu SJ; Yoon JH; Lee SH; Lee SM; Lee JH; Kim YJ; Lee HS; Kim CY
    J Cancer Res Clin Oncol; 2015 Nov; 141(11):2037-45. PubMed ID: 25989942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long Noncoding RNA MALAT1 Regulates Hepatocellular Carcinoma Growth Under Hypoxia via Sponging MicroRNA-200a.
    Zhao ZB; Chen F; Bai XF
    Yonsei Med J; 2019 Aug; 60(8):727-734. PubMed ID: 31347327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NDRG1 promotes growth of hepatocellular carcinoma cells by directly interacting with GSK-3β and Nur77 to prevent β-catenin degradation.
    Lu WJ; Chua MS; Wei W; So SK
    Oncotarget; 2015 Oct; 6(30):29847-59. PubMed ID: 26359353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MFN1-dependent alteration of mitochondrial dynamics drives hepatocellular carcinoma metastasis by glucose metabolic reprogramming.
    Zhang Z; Li TE; Chen M; Xu D; Zhu Y; Hu BY; Lin ZF; Pan JJ; Wang X; Wu C; Zheng Y; Lu L; Jia HL; Gao S; Dong QZ; Qin LX
    Br J Cancer; 2020 Jan; 122(2):209-220. PubMed ID: 31819189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein phosphatase 2A mediates JS-K-induced apoptosis by affecting Bcl-2 family proteins in human hepatocellular carcinoma HepG2 cells.
    Liu L; Huang Z; Chen J; Wang J; Wang S
    J Cell Biochem; 2018 Aug; 119(8):6633-6643. PubMed ID: 29693750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CENP-H regulates the cell growth of human hepatocellular carcinoma cells through the mitochondrial apoptotic pathway.
    Lu G; Hou H; Lu X; Ke X; Wang X; Zhang D; Zhao Y; Zhang J; Ren M; He S
    Oncol Rep; 2017 Jun; 37(6):3484-3492. PubMed ID: 28498417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-Myc down-regulated gene 1 mediates proliferation, invasion, and apoptosis of hepatocellular carcinoma cells.
    Yan X; Chua MS; Sun H; So S
    Cancer Lett; 2008 Apr; 262(1):133-42. PubMed ID: 18207320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-myc downstream regulated gene1/Cap43 overexpression suppresses tumor growth by hepatic cancer cells through cell cycle arrest at the G0/G1 phase.
    Akiba J; Murakami Y; Noda M; Watari K; Ogasawara S; Yoshida T; Kawahara A; Sanada S; Yasumoto M; Yamaguchi R; Kage M; Kuwano M; Ono M; Yano H
    Cancer Lett; 2011 Nov; 310(1):25-34. PubMed ID: 21775055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-139-5p inhibits aerobic glycolysis, cell proliferation, migration, and invasion in hepatocellular carcinoma via a reciprocal regulatory interaction with ETS1.
    Hua S; Lei L; Deng L; Weng X; Liu C; Qi X; Wang S; Zhang D; Zou X; Cao C; Liu L; Wu D
    Oncogene; 2018 Mar; 37(12):1624-1636. PubMed ID: 29335523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new facet of NDRG1 in pancreatic ductal adenocarcinoma: Suppression of glycolytic metabolism.
    Liu W; Zhang B; Hu Q; Qin Y; Xu W; Shi S; Liang C; Meng Q; Xiang J; Liang D; Ji S; Liu J; Hu P; Liu L; Liu C; Long J; Ni Q; Yu X; Xu J
    Int J Oncol; 2017 May; 50(5):1792-1800. PubMed ID: 28350132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.